- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
According to our latest study, the global Mesalamine market size was valued at USD 161 million in 2022 and is forecast to a readjusted size of USD 198.9 million by 2029 with a CAGR of 3.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively.
In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019.
This report is a detailed and comprehensive analysis for global Mesalamine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Mesalamine market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Mesalamine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Mesalamine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Mesalamine market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mesalamine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mesalamine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Syntese A/S, Divis Laboratories, Cambrex Corporation, Ipca Laboratories and Hangzhou Brother, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Mesalamine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%
Market segment by Application
Mesalazine Tablets
Mesalazine Capsules
Others
Major players covered
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
Hangzhou Brother
PharmaZell
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mesalamine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mesalamine, with price, sales, revenue and global market share of Mesalamine from 2018 to 2023.
Chapter 3, the Mesalamine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mesalamine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Mesalamine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mesalamine.
Chapter 14 and 15, to describe Mesalamine sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Mesalamine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Mesalamine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity ≥ 97%
1.3.3 Purity ≥ 98%
1.3.4 Purity ≥ 99%
1.4 Market Analysis by Application
1.4.1 Overview: Global Mesalamine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Mesalazine Tablets
1.4.3 Mesalazine Capsules
1.4.4 Others
1.5 Global Mesalamine Market Size & Forecast
1.5.1 Global Mesalamine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Mesalamine Sales Quantity (2018-2029)
1.5.3 Global Mesalamine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Syntese A/S
2.1.1 Syntese A/S Details
2.1.2 Syntese A/S Major Business
2.1.3 Syntese A/S Mesalamine Product and Services
2.1.4 Syntese A/S Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Syntese A/S Recent Developments/Updates
2.2 Divis Laboratories
2.2.1 Divis Laboratories Details
2.2.2 Divis Laboratories Major Business
2.2.3 Divis Laboratories Mesalamine Product and Services
2.2.4 Divis Laboratories Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Divis Laboratories Recent Developments/Updates
2.3 Cambrex Corporation
2.3.1 Cambrex Corporation Details
2.3.2 Cambrex Corporation Major Business
2.3.3 Cambrex Corporation Mesalamine Product and Services
2.3.4 Cambrex Corporation Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Cambrex Corporation Recent Developments/Updates
2.4 Ipca Laboratories
2.4.1 Ipca Laboratories Details
2.4.2 Ipca Laboratories Major Business
2.4.3 Ipca Laboratories Mesalamine Product and Services
2.4.4 Ipca Laboratories Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ipca Laboratories Recent Developments/Updates
2.5 Hangzhou Brother
2.5.1 Hangzhou Brother Details
2.5.2 Hangzhou Brother Major Business
2.5.3 Hangzhou Brother Mesalamine Product and Services
2.5.4 Hangzhou Brother Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hangzhou Brother Recent Developments/Updates
2.6 PharmaZell
2.6.1 PharmaZell Details
2.6.2 PharmaZell Major Business
2.6.3 PharmaZell Mesalamine Product and Services
2.6.4 PharmaZell Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 PharmaZell Recent Developments/Updates
2.7 Lianyungang Fengheng Biopharm
2.7.1 Lianyungang Fengheng Biopharm Details
2.7.2 Lianyungang Fengheng Biopharm Major Business
2.7.3 Lianyungang Fengheng Biopharm Mesalamine Product and Services
2.7.4 Lianyungang Fengheng Biopharm Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
2.8 Lasa Loboratory
2.8.1 Lasa Loboratory Details
2.8.2 Lasa Loboratory Major Business
2.8.3 Lasa Loboratory Mesalamine Product and Services
2.8.4 Lasa Loboratory Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Lasa Loboratory Recent Developments/Updates
2.9 Erregierre SpA
2.9.1 Erregierre SpA Details
2.9.2 Erregierre SpA Major Business
2.9.3 Erregierre SpA Mesalamine Product and Services
2.9.4 Erregierre SpA Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Erregierre SpA Recent Developments/Updates
2.10 Corden Pharma Bergamo
2.10.1 Corden Pharma Bergamo Details
2.10.2 Corden Pharma Bergamo Major Business
2.10.3 Corden Pharma Bergamo Mesalamine Product and Services
2.10.4 Corden Pharma Bergamo Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Corden Pharma Bergamo Recent Developments/Updates
2.11 CTX Lifescience
2.11.1 CTX Lifescience Details
2.11.2 CTX Lifescience Major Business
2.11.3 CTX Lifescience Mesalamine Product and Services
2.11.4 CTX Lifescience Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CTX Lifescience Recent Developments/Updates
2.12 Ishita Active Pharma Ingredients
2.12.1 Ishita Active Pharma Ingredients Details
2.12.2 Ishita Active Pharma Ingredients Major Business
2.12.3 Ishita Active Pharma Ingredients Mesalamine Product and Services
2.12.4 Ishita Active Pharma Ingredients Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Ishita Active Pharma Ingredients Recent Developments/Updates
2.13 YC Biotech (Jiangsu)
2.13.1 YC Biotech (Jiangsu) Details
2.13.2 YC Biotech (Jiangsu) Major Business
2.13.3 YC Biotech (Jiangsu) Mesalamine Product and Services
2.13.4 YC Biotech (Jiangsu) Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 YC Biotech (Jiangsu) Recent Developments/Updates
2.14 Xinxiang Tianfeng Fine Chemical
2.14.1 Xinxiang Tianfeng Fine Chemical Details
2.14.2 Xinxiang Tianfeng Fine Chemical Major Business
2.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Product and Services
2.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
3 Competitive Environment: Mesalamine by Manufacturer
3.1 Global Mesalamine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Mesalamine Revenue by Manufacturer (2018-2023)
3.3 Global Mesalamine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Mesalamine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Mesalamine Manufacturer Market Share in 2022
3.4.2 Top 6 Mesalamine Manufacturer Market Share in 2022
3.5 Mesalamine Market: Overall Company Footprint Analysis
3.5.1 Mesalamine Market: Region Footprint
3.5.2 Mesalamine Market: Company Product Type Footprint
3.5.3 Mesalamine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Mesalamine Market Size by Region
4.1.1 Global Mesalamine Sales Quantity by Region (2018-2029)
4.1.2 Global Mesalamine Consumption Value by Region (2018-2029)
4.1.3 Global Mesalamine Average Price by Region (2018-2029)
4.2 North America Mesalamine Consumption Value (2018-2029)
4.3 Europe Mesalamine Consumption Value (2018-2029)
4.4 Asia-Pacific Mesalamine Consumption Value (2018-2029)
4.5 South America Mesalamine Consumption Value (2018-2029)
4.6 Middle East and Africa Mesalamine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Mesalamine Sales Quantity by Type (2018-2029)
5.2 Global Mesalamine Consumption Value by Type (2018-2029)
5.3 Global Mesalamine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Mesalamine Sales Quantity by Application (2018-2029)
6.2 Global Mesalamine Consumption Value by Application (2018-2029)
6.3 Global Mesalamine Average Price by Application (2018-2029)
7 North America
7.1 North America Mesalamine Sales Quantity by Type (2018-2029)
7.2 North America Mesalamine Sales Quantity by Application (2018-2029)
7.3 North America Mesalamine Market Size by Country
7.3.1 North America Mesalamine Sales Quantity by Country (2018-2029)
7.3.2 North America Mesalamine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Mesalamine Sales Quantity by Type (2018-2029)
8.2 Europe Mesalamine Sales Quantity by Application (2018-2029)
8.3 Europe Mesalamine Market Size by Country
8.3.1 Europe Mesalamine Sales Quantity by Country (2018-2029)
8.3.2 Europe Mesalamine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Mesalamine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Mesalamine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Mesalamine Market Size by Region
9.3.1 Asia-Pacific Mesalamine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Mesalamine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Mesalamine Sales Quantity by Type (2018-2029)
10.2 South America Mesalamine Sales Quantity by Application (2018-2029)
10.3 South America Mesalamine Market Size by Country
10.3.1 South America Mesalamine Sales Quantity by Country (2018-2029)
10.3.2 South America Mesalamine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Mesalamine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Mesalamine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Mesalamine Market Size by Country
11.3.1 Middle East & Africa Mesalamine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Mesalamine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Mesalamine Market Drivers
12.2 Mesalamine Market Restraints
12.3 Mesalamine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Mesalamine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Mesalamine
13.3 Mesalamine Production Process
13.4 Mesalamine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Mesalamine Typical Distributors
14.3 Mesalamine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Mesalamine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Mesalamine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Syntese A/S Basic Information, Manufacturing Base and Competitors
Table 4. Syntese A/S Major Business
Table 5. Syntese A/S Mesalamine Product and Services
Table 6. Syntese A/S Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Syntese A/S Recent Developments/Updates
Table 8. Divis Laboratories Basic Information, Manufacturing Base and Competitors
Table 9. Divis Laboratories Major Business
Table 10. Divis Laboratories Mesalamine Product and Services
Table 11. Divis Laboratories Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Divis Laboratories Recent Developments/Updates
Table 13. Cambrex Corporation Basic Information, Manufacturing Base and Competitors
Table 14. Cambrex Corporation Major Business
Table 15. Cambrex Corporation Mesalamine Product and Services
Table 16. Cambrex Corporation Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Cambrex Corporation Recent Developments/Updates
Table 18. Ipca Laboratories Basic Information, Manufacturing Base and Competitors
Table 19. Ipca Laboratories Major Business
Table 20. Ipca Laboratories Mesalamine Product and Services
Table 21. Ipca Laboratories Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Ipca Laboratories Recent Developments/Updates
Table 23. Hangzhou Brother Basic Information, Manufacturing Base and Competitors
Table 24. Hangzhou Brother Major Business
Table 25. Hangzhou Brother Mesalamine Product and Services
Table 26. Hangzhou Brother Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Hangzhou Brother Recent Developments/Updates
Table 28. PharmaZell Basic Information, Manufacturing Base and Competitors
Table 29. PharmaZell Major Business
Table 30. PharmaZell Mesalamine Product and Services
Table 31. PharmaZell Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. PharmaZell Recent Developments/Updates
Table 33. Lianyungang Fengheng Biopharm Basic Information, Manufacturing Base and Competitors
Table 34. Lianyungang Fengheng Biopharm Major Business
Table 35. Lianyungang Fengheng Biopharm Mesalamine Product and Services
Table 36. Lianyungang Fengheng Biopharm Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Lianyungang Fengheng Biopharm Recent Developments/Updates
Table 38. Lasa Loboratory Basic Information, Manufacturing Base and Competitors
Table 39. Lasa Loboratory Major Business
Table 40. Lasa Loboratory Mesalamine Product and Services
Table 41. Lasa Loboratory Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Lasa Loboratory Recent Developments/Updates
Table 43. Erregierre SpA Basic Information, Manufacturing Base and Competitors
Table 44. Erregierre SpA Major Business
Table 45. Erregierre SpA Mesalamine Product and Services
Table 46. Erregierre SpA Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Erregierre SpA Recent Developments/Updates
Table 48. Corden Pharma Bergamo Basic Information, Manufacturing Base and Competitors
Table 49. Corden Pharma Bergamo Major Business
Table 50. Corden Pharma Bergamo Mesalamine Product and Services
Table 51. Corden Pharma Bergamo Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Corden Pharma Bergamo Recent Developments/Updates
Table 53. CTX Lifescience Basic Information, Manufacturing Base and Competitors
Table 54. CTX Lifescience Major Business
Table 55. CTX Lifescience Mesalamine Product and Services
Table 56. CTX Lifescience Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CTX Lifescience Recent Developments/Updates
Table 58. Ishita Active Pharma Ingredients Basic Information, Manufacturing Base and Competitors
Table 59. Ishita Active Pharma Ingredients Major Business
Table 60. Ishita Active Pharma Ingredients Mesalamine Product and Services
Table 61. Ishita Active Pharma Ingredients Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Ishita Active Pharma Ingredients Recent Developments/Updates
Table 63. YC Biotech (Jiangsu) Basic Information, Manufacturing Base and Competitors
Table 64. YC Biotech (Jiangsu) Major Business
Table 65. YC Biotech (Jiangsu) Mesalamine Product and Services
Table 66. YC Biotech (Jiangsu) Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. YC Biotech (Jiangsu) Recent Developments/Updates
Table 68. Xinxiang Tianfeng Fine Chemical Basic Information, Manufacturing Base and Competitors
Table 69. Xinxiang Tianfeng Fine Chemical Major Business
Table 70. Xinxiang Tianfeng Fine Chemical Mesalamine Product and Services
Table 71. Xinxiang Tianfeng Fine Chemical Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
Table 73. Global Mesalamine Sales Quantity by Manufacturer (2018-2023) & (MT)
Table 74. Global Mesalamine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Mesalamine Average Price by Manufacturer (2018-2023) & (USD/Kg)
Table 76. Market Position of Manufacturers in Mesalamine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Mesalamine Production Site of Key Manufacturer
Table 78. Mesalamine Market: Company Product Type Footprint
Table 79. Mesalamine Market: Company Product Application Footprint
Table 80. Mesalamine New Market Entrants and Barriers to Market Entry
Table 81. Mesalamine Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Mesalamine Sales Quantity by Region (2018-2023) & (MT)
Table 83. Global Mesalamine Sales Quantity by Region (2024-2029) & (MT)
Table 84. Global Mesalamine Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Mesalamine Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Mesalamine Average Price by Region (2018-2023) & (USD/Kg)
Table 87. Global Mesalamine Average Price by Region (2024-2029) & (USD/Kg)
Table 88. Global Mesalamine Sales Quantity by Type (2018-2023) & (MT)
Table 89. Global Mesalamine Sales Quantity by Type (2024-2029) & (MT)
Table 90. Global Mesalamine Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Mesalamine Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Mesalamine Average Price by Type (2018-2023) & (USD/Kg)
Table 93. Global Mesalamine Average Price by Type (2024-2029) & (USD/Kg)
Table 94. Global Mesalamine Sales Quantity by Application (2018-2023) & (MT)
Table 95. Global Mesalamine Sales Quantity by Application (2024-2029) & (MT)
Table 96. Global Mesalamine Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Mesalamine Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Mesalamine Average Price by Application (2018-2023) & (USD/Kg)
Table 99. Global Mesalamine Average Price by Application (2024-2029) & (USD/Kg)
Table 100. North America Mesalamine Sales Quantity by Type (2018-2023) & (MT)
Table 101. North America Mesalamine Sales Quantity by Type (2024-2029) & (MT)
Table 102. North America Mesalamine Sales Quantity by Application (2018-2023) & (MT)
Table 103. North America Mesalamine Sales Quantity by Application (2024-2029) & (MT)
Table 104. North America Mesalamine Sales Quantity by Country (2018-2023) & (MT)
Table 105. North America Mesalamine Sales Quantity by Country (2024-2029) & (MT)
Table 106. North America Mesalamine Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Mesalamine Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Mesalamine Sales Quantity by Type (2018-2023) & (MT)
Table 109. Europe Mesalamine Sales Quantity by Type (2024-2029) & (MT)
Table 110. Europe Mesalamine Sales Quantity by Application (2018-2023) & (MT)
Table 111. Europe Mesalamine Sales Quantity by Application (2024-2029) & (MT)
Table 112. Europe Mesalamine Sales Quantity by Country (2018-2023) & (MT)
Table 113. Europe Mesalamine Sales Quantity by Country (2024-2029) & (MT)
Table 114. Europe Mesalamine Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Mesalamine Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Mesalamine Sales Quantity by Type (2018-2023) & (MT)
Table 117. Asia-Pacific Mesalamine Sales Quantity by Type (2024-2029) & (MT)
Table 118. Asia-Pacific Mesalamine Sales Quantity by Application (2018-2023) & (MT)
Table 119. Asia-Pacific Mesalamine Sales Quantity by Application (2024-2029) & (MT)
Table 120. Asia-Pacific Mesalamine Sales Quantity by Region (2018-2023) & (MT)
Table 121. Asia-Pacific Mesalamine Sales Quantity by Region (2024-2029) & (MT)
Table 122. Asia-Pacific Mesalamine Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Mesalamine Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Mesalamine Sales Quantity by Type (2018-2023) & (MT)
Table 125. South America Mesalamine Sales Quantity by Type (2024-2029) & (MT)
Table 126. South America Mesalamine Sales Quantity by Application (2018-2023) & (MT)
Table 127. South America Mesalamine Sales Quantity by Application (2024-2029) & (MT)
Table 128. South America Mesalamine Sales Quantity by Country (2018-2023) & (MT)
Table 129. South America Mesalamine Sales Quantity by Country (2024-2029) & (MT)
Table 130. South America Mesalamine Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Mesalamine Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Mesalamine Sales Quantity by Type (2018-2023) & (MT)
Table 133. Middle East & Africa Mesalamine Sales Quantity by Type (2024-2029) & (MT)
Table 134. Middle East & Africa Mesalamine Sales Quantity by Application (2018-2023) & (MT)
Table 135. Middle East & Africa Mesalamine Sales Quantity by Application (2024-2029) & (MT)
Table 136. Middle East & Africa Mesalamine Sales Quantity by Region (2018-2023) & (MT)
Table 137. Middle East & Africa Mesalamine Sales Quantity by Region (2024-2029) & (MT)
Table 138. Middle East & Africa Mesalamine Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Mesalamine Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Mesalamine Raw Material
Table 141. Key Manufacturers of Mesalamine Raw Materials
Table 142. Mesalamine Typical Distributors
Table 143. Mesalamine Typical Customers
List of Figures
Figure 1. Mesalamine Picture
Figure 2. Global Mesalamine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Mesalamine Consumption Value Market Share by Type in 2022
Figure 4. Purity ≥ 97% Examples
Figure 5. Purity ≥ 98% Examples
Figure 6. Purity ≥ 99% Examples
Figure 7. Global Mesalamine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Mesalamine Consumption Value Market Share by Application in 2022
Figure 9. Mesalazine Tablets Examples
Figure 10. Mesalazine Capsules Examples
Figure 11. Others Examples
Figure 12. Global Mesalamine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Mesalamine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Mesalamine Sales Quantity (2018-2029) & (MT)
Figure 15. Global Mesalamine Average Price (2018-2029) & (USD/Kg)
Figure 16. Global Mesalamine Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Mesalamine Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Mesalamine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Mesalamine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Mesalamine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Mesalamine Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Mesalamine Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Mesalamine Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Mesalamine Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Mesalamine Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Mesalamine Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Mesalamine Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Mesalamine Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Mesalamine Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Mesalamine Average Price by Type (2018-2029) & (USD/Kg)
Figure 31. Global Mesalamine Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Mesalamine Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Mesalamine Average Price by Application (2018-2029) & (USD/Kg)
Figure 34. North America Mesalamine Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Mesalamine Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Mesalamine Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Mesalamine Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Mesalamine Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Mesalamine Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Mesalamine Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Mesalamine Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Mesalamine Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Mesalamine Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Mesalamine Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Mesalamine Consumption Value Market Share by Region (2018-2029)
Figure 54. China Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Mesalamine Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Mesalamine Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Mesalamine Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Mesalamine Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Mesalamine Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Mesalamine Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Mesalamine Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Mesalamine Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Mesalamine Market Drivers
Figure 75. Mesalamine Market Restraints
Figure 76. Mesalamine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Mesalamine in 2022
Figure 79. Manufacturing Process Analysis of Mesalamine
Figure 80. Mesalamine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
